Table of Contents Table of Contents
Previous Page  45 / 398 Next Page
Information
Show Menu
Previous Page 45 / 398 Next Page
Page Background

40

Abstracts

We report on our 10-year experience of both intra and extraoral

implants and the effects of radiotherapy.

http://dx.doi.org/10.1016/j.ijom.2017.02.146

Pharyngeal reconstruction

S. Parmar

University Hospital Birmingham, Birmingham, United Kingdom

Reconstruction of the pharyngolaryngectomy defect is difficult

due to poor surrounding tissues whose vascularity is often com-

plicated by the effects of radiotherapy.

Many modes of reconstruction have been recommended and

we will present one of the largest jejunal series in the world

and our experience with the anterolateral thigh will also be

discussed.

http://dx.doi.org/10.1016/j.ijom.2017.02.147

Jaw reconstruction assisted by computer techniques

X. Peng

Peking University School of Stomatology, Beijing, China

Mandibular and maxillary defects resulted from tumour resection

and trauma may cause severe functional and cosmetic deformities.

The vascularised fibula and deep circumflex iliac artery (DCIA)

flap are already widely used in maxillofacial reconstruction.

The success of jaw reconstruction generally depends on the sur-

geons’ experience, and although acceptable results are achieved in

many patients, some degree of patient dissatisfaction does occur

because the conventional surgical approach lacks an objective

design process. Computer-aided design/computer-aided manufac-

turing techniques, such as virtual planning, rapid prototyping,

reverse engineering and surgical navigation, can be used to

improve the process. The experience at Peking University is

introduced.

The three-dimensional position of the fibula flap in computer-

assisted group is significantly more accurate and ideal than

the traditional group. The average difference between the real

postoperative position and virtual planning of the fibula in the

computer-assisted group was less than 5 mm. Application of com-

puter techniques can significantly improve the clinical outcome

of maxillary and mandibular defect reconstruction with free fibula

and DCIA flap.

http://dx.doi.org/10.1016/j.ijom.2017.02.148

Contemporary management of advanced gingivobuccal and

tongue carcinomas: perspective from the subcontinent

V. Pillai

Mazumdar Shaw Cancer Centre, Bangalore, India

Oral cancer accounts for the majority of head and neck cancers in

the Indian subcontinent that can be attributed to the use of tobacco

both in the chewable and smoked forms.

The magnitude of the problem can be perceived from: (1) lack

of education, awareness and thus advanced stage of presentation,

(2) economic implications of treatment and paucity of trained

personnel and competent institutions to address the problem and

(3) differing and variable philosophies of thought about treatment

principles.

Advanced buccal mucosa carcinoma and tongue carcinomas

are considered moderately advanced disease based on current

staging principles.

Though guidelines are ambiguous about respectability, this

has contributed to a surging interest in the use of neoadjuvant

chemotherapy for the management of these patients. The ratio-

nale underlying this is debatable. However its widespread use often

delays definitive “curative” intent surgical modalities of treatment.

Very often most of these patients are relegated to palliative intent

treatment.

The management of advanced carcinomas of the gingivobuccal

and tongue has two endpoints: oncologic and functional outcome.

To decide which modality namely surgical versus nonsurgical

is superior one needs to assess both these endpoints as these would

provide best levels of evidence in deciding the superiority of one

over the other. Tumour differentiation, nodal involvement, extra-

capsular spread and perineural invasion are significant prognostic

determinants of outcome. Functional endpoints primarily relate to

airway, speech and oral intake.

This symposium would focus on current scientific evidence,

our experience and future pathways in the management of advance

oral carcinomas of these two subsets.

http://dx.doi.org/10.1016/j.ijom.2017.02.149

Investigating the neck in oral squamous cell carcinoma

V. Pillai

Mazumdar Shaw Cancer Centre, Bangalore, India

The assessment of the neck in oral squamous cell carcinoma

(OSCC) is critical for staging and it precedes further manage-

ment, it also predicts disease specific survival, and recurrence is

the hallmark of a malignant phenotype.

Investigation by imaging and tissue diagnosis are both crucial

to further management.

This presentation review various evidence-based modalities in

current clinical practice along with an algorithmic approach to the

assessment of the neck.

The various imaging modalities are computed tomography

(CT), magnetic resonance imaging (MRI) and positron emis-

sion tomography (PET) CT. Tissue diagnosis is commonly

obtained by ultrasound-guided (USG) fine-needle aspiration cytol-

ogy (FNAC). Sentinel lymph node biopsy (SLNB) and categorised

biomarkers and gene expression profiles are the newer tools in the

armamentarium.

USG FNAC has a specificity approaching nearly 100% for the

evaluation of nodal disease. Drawbacks are its operator sensitivity

and expertise required for nodes less than 5 mm.

With CT or MRI between 40 and 60% of all occult metastasis

can be detected.

PET CT has an advantage of combining anatomical and func-

tional imaging, however false positives due to physiologic uptake

and inflammation are high. Its drawbacks are for metastatic

deposits less than 5 mm and low sensitivity in the N0 neck ranging

from 25 to 78%. It has a role in the recurrent and salvage settings.

SLNB for early T1 and T2 lesions is a promising tool as it

avoids the morbidity due to a neck dissection. With negative pre-

dictive value (NPV) from the 2 major trials ranging between 88

and 98% it is a very promising tool. Combined with frozen section

it has a NPV of 83%.

Cancer stem cells have been implicated in tumourigenesis and

chemoresistance. Methylation markers such as Wnt-1 induced

secreted protein 1 (WISP1) and programmed cell death ligand